Associations of Coffee Consumption with Markers of Liver Injury in the Insulin Resistance Atherosclerosis Study

Overview

Journal BMC Gastroenterol

Publisher Biomed Central

Specialty Gastroenterology

Date 2015 Jul 29

PMID 26215323

Citations 3

Authors

J C Dickson

A D Liese

C Lorenzo

S M Haffner

S M Watkins

S J Hamren

J K Stiles

L E Wagenknecht

A J Hanley

Affiliations

Soon will be listed here.

Abstract

Background: Coffee consumption has been associated with reduced risk of developing type 2 diabetes mellitus (T2DM) however, the mechanism for this association has yet to be elucidated. Non-alcoholic fatty liver disease (NAFLD) characterizes and predicts T2DM yet the relationship of coffee with this disorder remains unclear. Our aim was to investigate the associations of coffee with markers of liver injury in 1005 multi-ethnic, non-diabetic adults in the Insulin Resistance Atherosclerosis Study.

Methods: Dietary intake was assessed using a validated 114-item food frequency questionnaire. Alanine aminotransferase (ALT), aspartate aminotransferase (AST) and fetuin-A were determined in fasting blood samples and the validated NAFLD liver fat score was calculated. Multivariate linear regression assessed the contribution of coffee to variation in markers of liver injury.

Results: Caffeinated coffee showed significant inverse associations with ALT (β = -0.08, p = 0.0111), AST (β = -0.05, p = 0.0155) and NAFLD liver fat score (β = -0.05, p = 0.0293) but not with fetuin-A (β = 0.04, p = 0.17). When the highest alcohol consumers were excluded, these associations remained (ALT β = -0.11, p = 0.0037; AST β = -0.05, p = 0.0330; NAFLD liver fat score β = -0.06, p = 0.0298). With additional adjustment for insulin sensitivity, the relationship with ALT remained significant (ALT β = -0.08, p = 0.0400; AST β = -0.03, p = 0.20; NAFLD liver fat score β = -0.03, p = 0.27). There were no significant associations of decaffeinated coffee with liver markers.

Conclusions: These analyses indicate a beneficial impact of caffeinated coffee on liver morphology and/or function, and suggest that this relationship may mediate the well-established inverse association of coffee with risk of T2DM.

Citing Articles

An umbrella review of the evidence associating diet and cancer risk at 11 anatomical sites.

Papadimitriou N, Markozannes G, Kanellopoulou A, Critselis E, Alhardan S, Karafousia V Nat Commun. 2021; 12(1):4579.

PMID: 34321471 PMC: 8319326. DOI: 10.1038/s41467-021-24861-8.

Metabolites, Nutrients, and Lifestyle Factors in Relation to Coffee Consumption: An Environment-Wide Association Study.

Elhadad M, Karavasiloglou N, Wulaningsih W, Tsilidis K, Tzoulaki I, Patel C Nutrients. 2020; 12(5).

PMID: 32438643 PMC: 7284649. DOI: 10.3390/nu12051470.

Coffee prevents fatty liver disease induced by a high-fat diet by modulating pathways of the gut-liver axis.

Vitaglione P, Mazzone G, Lembo V, DArgenio G, Rossi A, Guido M J Nutr Sci. 2019; 8:e15.

PMID: 31037218 PMC: 6477661. DOI: 10.1017/jns.2019.10.

References

Honjo S, Kono S, Coleman M, Shinchi K, Sakurai Y, TODOROKI I . Coffee drinking and serum gamma-glutamyltransferase: an extended study of Self-Defense Officials of Japan. Ann Epidemiol. 2000; 9(5):325-31. DOI: 10.1016/s1047-2797(99)00013-7. View

Salvini S, Hunter D, Sampson L, Stampfer M, Colditz G, Rosner B . Food-based validation of a dietary questionnaire: the effects of week-to-week variation in food consumption. Int J Epidemiol. 1989; 18(4):858-67. DOI: 10.1093/ije/18.4.858. View

Klatsky A, Morton C, Udaltsova N, Friedman G . Coffee, cirrhosis, and transaminase enzymes. Arch Intern Med. 2006; 166(11):1190-5. DOI: 10.1001/archinte.166.11.1190. View

Kim C, Park J, Lee K, Kim J, Kim H . Fatty liver is an independent risk factor for the development of Type 2 diabetes in Korean adults. Diabet Med. 2008; 25(4):476-81. DOI: 10.1111/j.1464-5491.2008.02410.x. View

Wedick N, Brennan A, Sun Q, Hu F, Mantzoros C, van Dam R . Effects of caffeinated and decaffeinated coffee on biological risk factors for type 2 diabetes: a randomized controlled trial. Nutr J. 2011; 10:93. PMC: 3180352. DOI: 10.1186/1475-2891-10-93. View

Okamoto M, Takeda Y, Yoda Y, Kobayashi K, A Fujino M, Yamagata Z . The association of fatty liver and diabetes risk. J Epidemiol. 2003; 13(1):15-21. PMC: 9538608. DOI: 10.2188/jea.13.15. View

Muriel P, Arauz J . Coffee and liver diseases. Fitoterapia. 2009; 81(5):297-305. DOI: 10.1016/j.fitote.2009.10.003. View

Molloy J, Calcagno C, Williams C, Jones F, Torres D, Harrison S . Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis. Hepatology. 2011; 55(2):429-36. DOI: 10.1002/hep.24731. View

Jacobs S, Kroger J, Floegel A, Boeing H, Drogan D, Pischon T . Evaluation of various biomarkers as potential mediators of the association between coffee consumption and incident type 2 diabetes in the EPIC-Potsdam Study. Am J Clin Nutr. 2014; 100(3):891-900. DOI: 10.3945/ajcn.113.080317. View

10.

Catalano D, Martines G, Tonzuso A, Pirri C, Trovato F, Trovato G . Protective role of coffee in non-alcoholic fatty liver disease (NAFLD). Dig Dis Sci. 2010; 55(11):3200-6. DOI: 10.1007/s10620-010-1143-3. View

11.

Westerbacka J, Corner A, Tiikkainen M, Tamminen M, Vehkavaara S, Hakkinen A . Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: implications for sex differences in markers of cardiovascular risk. Diabetologia. 2004; 47(8):1360-9. DOI: 10.1007/s00125-004-1460-1. View

12.

Liese A, Schulz M, Moore C, Mayer-Davis E . Dietary patterns, insulin sensitivity and adiposity in the multi-ethnic Insulin Resistance Atherosclerosis Study population. Br J Nutr. 2004; 92(6):973-84. DOI: 10.1079/bjn20041279. View

13.

Yamashita K, Yatsuya H, Muramatsu T, Toyoshima H, Murohara T, Tamakoshi K . Association of coffee consumption with serum adiponectin, leptin, inflammation and metabolic markers in Japanese workers: a cross-sectional study. Nutr Diabetes. 2012; 2:e33. PMC: 3347755. DOI: 10.1038/nutd.2012.6. View

14.

Yki-Jarvinen H . Liver fat in the pathogenesis of insulin resistance and type 2 diabetes. Dig Dis. 2010; 28(1):203-9. DOI: 10.1159/000282087. View

15.

Pacini G, Bergman R . MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput Methods Programs Biomed. 1986; 23(2):113-22. DOI: 10.1016/0169-2607(86)90106-9. View

16.

Nakanishi N, Nakamura K, Nakajima K, Suzuki K, Tatara K . Coffee consumption and decreased serum gamma-glutamyltransferase: a study of middle-aged Japanese men. Eur J Epidemiol. 2000; 16(5):419-23. DOI: 10.1023/a:1007683626665. View

17.

Mayer-Davis E, DAgostino Jr R, Karter A, Haffner S, Rewers M, Saad M . Intensity and amount of physical activity in relation to insulin sensitivity: the Insulin Resistance Atherosclerosis Study. JAMA. 1998; 279(9):669-74. DOI: 10.1001/jama.279.9.669. View

18.

Birerdinc A, Stepanova M, Pawloski L, Younossi Z . Caffeine is protective in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2011; 35(1):76-82. DOI: 10.1111/j.1365-2036.2011.04916.x. View

19.

Hanley A, Williams K, Festa A, Wagenknecht L, DAgostino Jr R, Kempf J . Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes. 2004; 53(10):2623-32. DOI: 10.2337/diabetes.53.10.2623. View

20.

Ruhl C, Everhart J . Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States. Gastroenterology. 2005; 128(1):24-32. DOI: 10.1053/j.gastro.2004.09.075. View